Dr. Malek is a physician scientist and professor of hematology/oncology working at the University of Michigan, Ann Arbor, USA.  He obtained his MD from the University of Hamburg/Germany and subsequently trained in Molecular Biology at Johns Hopkins.  He completed clinical training in Internal Medicine at Baylor College of Medicine and a combined fellowship in Hematology and Oncology at Johns Hopkins with a research portion at Columbia University.  The Malek lab is studying the genomics of hematological malignancies with efforts in CLL, AML and more recently Follicular Lymphoma.  Findings from genomic analyses inform on the basic biology of blood cancers and allow for novel translational clinical directions.  Recent examples of work from the lab include the development of novel MRD assays in AML and the dynamics of AML evolution at relapse from therapy. Another focus area is the identification and functional characterization of multiple novel recurrently mutated genes in FL.